ccri
mice
obtain
system
genet
core
facil
univers
north
carolinachapel
hill
unc
mice
ccrix
gener
research
studi
unc
specif
pathogenfre
spf
facil
base
follow
principl
ccri
strain
use
cross
certifi
distribut
unc
system
genet
core
facil
abl
provid
us
suffici
breed
anim
program
gener
n
anim
target
window
ccrix
parent
haplotyp
either
founder
parent
haplotyp
cc
founder
strain
ccri
use
least
prefer
dam
prefer
sire
relev
ccrix
final
includ
ccrix
multipl
time
across
year
program
specif
assess
control
batch
season
effect
use
ccrix
allow
us
explor
line
limit
number
avail
ri
strain
addit
ccrix
line
bred
ensur
line
heterozyg
locu
copi
haplotyp
copi
variou
haplotyp
design
select
could
examin
antigenspecif
tcell
respons
parallel
studi
immunogenet
viru
infect
concurr
maintain
genet
variat
throughout
rest
genom
six
eightweekold
hybrid
male
mice
transfer
unc
univers
washington
uw
hous
directli
biosafeti
level
bsl
laboratori
within
spf
barrier
facil
male
mice
use
baselin
immun
wnv
experi
mice
per
experiment
group
concurr
femal
hybrid
mice
transfer
either
sarscov
cubicl
facil
influenza
unc
mice
allow
acclim
week
infect
week
age
anim
experi
approv
uw
unc
institut
anim
care
use
committe
offic
laboratori
anim
welfar
nation
institut
health
approv
unc
uw
studi
carri
strict
complianc
public
health
servic
polici
human
care
use
laboratori
anim
west
nile
viru
wntx
propag
previous
describ
mice
subcutan
sc
inocul
rear
footpad
plaqueform
unit
pfu
wntx
mice
monitor
daili
morbid
percentag
initi
weight
loss
clinic
diseas
score
mouseadapt
sarscov
propag
titter
vero
cell
previous
describ
mice
intranas
infect
pfu
sarscov
measur
daili
weight
loss
mice
exhibit
extrem
weight
loss
sign
clinic
diseas
observ
time
day
euthan
necessari
base
human
endpoint
influenza
viru
gener
revers
genet
system
mdck
cell
mice
inocul
intranas
pfu
viru
phosphatebuff
salin
mice
monitor
daili
morbid
mortal
viru
inoculum
dose
select
base
dose
caus
rang
suscept
phenotyp
founder
strain
previou
studi
virus
done
background
dose
test
founder
line
ensur
rang
suscept
mortal
immun
respons
exampl
mice
succumb
pfu
wnv
deliv
sc
founder
line
greater
mortal
other
mortal
aim
maxim
phenotyp
divers
still
maintain
suffici
surviv
could
assess
immun
phenotyp
variou
time
postinfect
spleen
prepar
flow
cytometri
stain
previous
describ
antibodi
test
use
cell
cc
founder
strain
confirm
antibodi
clone
compat
cc
use
test
compar
group
mannwhitney
test
conduct
p
consid
signific
error
bar
error
mean
although
mani
studi
sought
identifi
immun
correl
protect
singl
viru
infect
use
multipl
infect
model
identifi
global
conserv
immun
correl
protect
mortal
viru
infect
thu
use
infect
mice
differ
virus
flu
sarscov
infect
respiratori
tract
host
well
wnv
mosquitoborn
neurotrop
infect
focus
mortal
endpoint
indic
sever
diseas
uniqu
clinic
manifest
infect
make
score
difficult
screen
mice
differ
ccrix
line
infect
virus
follow
monitor
surviv
day
postinfect
analysi
identifi
ccrix
mortal
infect
virus
mortal
line
degre
mortal
mortal
three
result
identif
line
mortal
line
mortal
provid
high
low
suscept
cohort
downstream
studi
tabl
ccrix
intermedi
mortal
phenotyp
lack
immun
cell
phenotyp
data
includ
subsequ
analysi
list
supplementari
tabl
determin
baselin
immun
signatur
correl
mortal
examin
frequenc
differ
popul
phenotyp
cell
within
spleen
steadi
state
assess
second
cohort
agematch
mice
line
supplementari
figur
found
statist
lower
tcell
ratio
preinfect
mice
line
experienc
mortal
infect
figur
differ
frequenc
cell
frequenc
cell
significantli
lower
higher
fraction
cell
mice
line
experienc
mortal
infect
wnv
sarscov
flu
figur
data
suggest
higher
baselin
tcell
level
compar
cell
correl
reduc
risk
mortal
along
differ
tcell
ratio
significantli
elev
frequenc
memoryphenotypelik
cell
mice
line
mortal
infect
virus
figur
c
addit
increas
frequenc
cell
correl
surviv
upon
infect
also
increas
preinfect
frequenc
activ
cell
present
mice
line
surviv
subsequ
infect
particular
increas
frequenc
cell
figur
cell
figur
cell
figur
thu
presenc
increas
fraction
activ
cell
recent
prolifer
andor
pois
respond
signal
direct
lymphoid
tissu
distant
tissu
site
viru
activ
replic
may
also
confer
surviv
advantag
viru
infect
data
taken
togeth
suggest
mice
resist
infectioninduc
mortal
maintain
skew
toward
higher
tcell
level
higher
baselin
tcell
activ
anim
lower
surviv
build
find
next
assess
frequenc
baselin
splenic
cell
express
transcript
factor
tbet
indic
phenotyp
link
secret
interferon
ifn
known
potent
antivir
cytokin
although
differ
tbet
express
cell
mortal
versu
mortal
group
figur
statist
signific
increas
tbet
cell
line
mortal
figur
hypothes
may
predispos
cell
mice
line
rapidli
particip
antivir
respons
contrast
increas
frequenc
induc
costimul
ico
cell
line
mortal
figur
demonstr
ico
play
role
immun
viru
infect
includ
flu
lymphocyt
choriomening
viru
vesicular
stomat
viru
level
antibodi
respons
germin
center
format
tcell
respons
therebi
suggest
steadyst
reduct
ico
express
cell
could
result
impair
antivir
respons
howev
also
possibl
attenu
immun
infect
could
result
diminish
immunemedi
patholog
could
benefit
host
term
surviv
inde
although
robust
antipathogen
immun
respons
rapidli
clear
viru
also
come
cost
enhanc
destruct
infect
tissu
previou
studi
test
treatment
fluinfect
mice
antiico
antibodi
found
reduc
pulmonari
tcell
inflamm
thu
indic
potenti
mechan
wherebi
reduc
ico
express
could
benefit
host
surviv
viru
infect
reduct
tissuespecif
inflamm
base
find
distinct
baselin
tcell
activ
state
may
play
role
protect
sever
clinic
outcom
mortal
viral
infect
figur
next
examin
steadyst
regulatori
tcell
treg
frequenc
phenotyp
spleen
significantli
higher
baselin
frequenc
treg
figur
well
increas
frequenc
treg
express
activ
marker
glucocorticoidinduc
tumor
necrosi
factor
tnf
receptor
gitr
figur
c
present
mice
line
protect
death
infect
consist
notion
homeostat
state
immun
quiescenc
mediat
least
part
treg
could
play
role
protect
sever
clinic
outcom
viru
infect
interest
note
found
decreas
frequenc
treg
express
mice
line
mortal
viru
infect
figur
supplementari
figur
express
afford
treg
abil
competit
consum
interleukin
il
therebi
depriv
convent
cell
essenti
cytokin
thu
restrict
expans
thu
possibl
reduc
frequenc
treg
indic
less
andor
alter
suppress
capac
treg
could
critic
maintain
balanc
robust
immun
clear
viru
limit
immunopathologydriven
diseas
morbid
mortal
investig
hypothesi
need
balanc
state
appropri
tune
immun
respons
surviv
viral
infect
examin
tcell
capac
produc
cytokin
steadi
state
differ
tcell
tcell
product
baselin
mice
line
without
mortal
figur
although
frequenc
cell
produc
low
baselin
signific
increas
fraction
cell
produc
mice
line
protect
death
viral
challeng
figur
e
supplementari
tabl
cell
best
known
role
immunosurveil
mucos
barrier
surfac
mani
autoimmun
inflammatori
diseas
role
intracellular
viral
infect
remain
unclear
evid
protect
patholog
role
final
observ
reduc
frequenc
cell
produc
baselin
associ
protect
mortal
upon
viru
infect
figur
f
hypothes
propens
produc
proinflammatori
cytokin
could
play
detriment
role
immunemedi
tissu
damag
upon
infect
consist
previou
find
sarscov
perhap
could
serv
biomark
individu
may
higher
risk
sever
clinic
diseas
upon
viru
infect
use
cc
mice
combin
larg
screen
postinfect
mortal
infect
flu
sarscov
wnv
identifi
immun
correl
protect
sever
clinic
outcom
indic
death
studi
identifi
sever
baselin
immunolog
featur
may
contribut
protect
sever
diseas
clinic
outcom
upon
viru
infect
mani
kind
includ
lower
tcell
ratio
therebi
indic
cell
may
play
key
role
mediat
balanc
clear
pathogen
spare
collater
damag
host
tissu
moreov
increas
level
basal
tcell
activ
associ
protect
given
marker
associ
tcell
memori
one
marker
found
signatur
figur
c
possibl
rapid
bystand
activ
may
play
critic
role
protect
respons
cell
may
repres
true
memori
cell
result
previou
microbi
exposur
mice
hous
specif
pathogenfre
spf
germfre
condit
altern
cell
could
also
repres
unconvent
memori
phenotyp
cell
acquir
memori
phenotyp
without
exposur
cognat
antigen
either
case
howev
possibl
cell
could
particip
earli
viral
control
bystandermedi
action
thu
potenti
confer
surviv
advantag
host
rapid
viral
contain
gener
virusspecif
tcell
respons
inde
would
consist
previou
find
unconvent
memori
cell
prolifer
rapidli
respons
antigen
particip
protect
immun
pathogen
listeria
monocytogen
influenza
viru
addit
found
increas
frequenc
treg
uniqu
suppress
profil
correl
protect
figur
support
notion
balanc
activ
immun
suppress
like
critic
spare
host
sever
diseas
infect
previous
found
treg
play
role
protect
human
immunodefici
viru
infect
analysi
casecontrol
cohort
addit
preced
treg
play
role
protect
immunopatholog
infect
furthermor
previous
shown
treg
activ
requir
viral
infect
allow
appropri
gener
migrat
immun
effector
cell
site
infect
thu
possibl
increas
treg
abund
express
suppress
marker
gitr
play
role
coordin
effect
antivir
immun
altern
also
possibl
treg
could
assist
attenu
antivir
immun
upon
viral
clearanc
therebi
spare
host
addit
collater
damag
could
associ
prolong
activ
immun
respons
result
taken
togeth
argu
augment
target
tcell
respons
play
role
resist
viralinduc
mortal
final
reduc
steadyst
tcell
capac
produc
proinflammatori
cytokin
correl
protect
consist
less
risk
collater
damag
upon
tcell
receptormedi
stimul
hypothes
memoryphenotyp
cell
found
greater
steadyst
abund
ccrix
suffer
mortal
upon
infect
confer
protect
via
canon
antigenspecif
true
memori
mediat
mechan
cytokin
product
instead
specul
cell
becom
bystanderactiv
inflamm
associ
infect
thu
acquir
cytotox
function
could
mediat
altern
pathway
target
cell
kill
altogeth
observ
distinguish
tcell
profil
associ
protect
viralinduc
mortal
due
natur
larg
collabor
studi
use
thousand
mice
cours
sever
year
limit
discuss
mice
project
obtain
system
genet
core
facil
locat
unc
mice
use
flu
sarscov
experi
unc
wnv
experi
includ
flow
cytometrybas
immun
phenotyp
naiv
infect
mice
uw
reduc
amount
breed
well
product
use
mice
use
femal
mice
flu
sarscov
studi
unc
male
mice
use
wnv
studi
uw
thu
although
male
use
baselin
splenic
immunophenotyp
male
wnv
femal
influenza
sarscov
use
infect
studi
yield
data
mortal
ensur
correl
protect
identifi
analysi
sexspecif
moreov
examin
immun
cell
spleen
flow
cytometri
measur
preinfect
immun
phenotyp
examin
blood
viral
target
tissu
lung
use
flow
cytometri
panel
thu
specul
preinfect
lung
immunophenotyp
associ
viral
infect
outcom
addit
human
data
come
analysi
immun
cell
within
blood
although
analysi
immun
cell
within
spleen
use
predict
might
protect
human
common
tissu
type
analyz
thu
direct
bloodtoblood
comparison
possibl
studi
addit
major
immun
phenotyp
screen
repres
tcell
phenotyp
like
innat
humor
immun
state
could
associ
mortal
warrant
studi
final
although
result
present
herein
demonstr
associ
set
baselin
tcell
immunophenotyp
protect
mortal
upon
infect
ribonucl
acid
virus
test
predict
mechanist
studi
howev
specul
singl
immun
phenotyp
sole
drive
protect
mortal
predict
block
augment
singl
immun
phenotyp
alon
would
significantli
alter
degre
mortal
upon
infect
overal
result
defin
distinct
baselin
tcell
correl
associ
surviv
viral
challeng
studi
identifi
specif
basal
immun
characterist
associ
protect
mortal
upon
viru
infect
also
underscor
need
protect
immun
respons
balanc
protect
host
uncontrol
viru
replic
also
diseas
associ
robust
immun
although
valid
studi
human
requir
confirm
correl
protect
sever
clinic
diseas
viru
infect
possibl
knowledg
advanc
effort
design
vaccin
infect
prevent
strategi
likewis
tcell
profil
inform
method
screen
individu
increas
risk
sever
clinic
diseas
upon
viru
infect
import
approach
highlight
util
explor
multipl
infect
context
genet
divers
popul
